CO6650378A2 - Derivados de cis -tetrahidro -espiro(ciclohexan-1.1-pirido[-3.4-b]indol)4-amina - Google Patents

Derivados de cis -tetrahidro -espiro(ciclohexan-1.1-pirido[-3.4-b]indol)4-amina

Info

Publication number
CO6650378A2
CO6650378A2 CO13014969A CO13014969A CO6650378A2 CO 6650378 A2 CO6650378 A2 CO 6650378A2 CO 13014969 A CO13014969 A CO 13014969A CO 13014969 A CO13014969 A CO 13014969A CO 6650378 A2 CO6650378 A2 CO 6650378A2
Authority
CO
Colombia
Prior art keywords
pain
pyrido
indole
tetrahydro
cis
Prior art date
Application number
CO13014969A
Other languages
English (en)
Inventor
Klaus Linz
Saskia Zemolka
Bert Nolte
Stefan Schunk
Hans Schick
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44315152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6650378(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of CO6650378A2 publication Critical patent/CO6650378A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a los derivados de amina cis-tetrahidro-espiro(ciclohexán1,1 -pirido[3,4-b]indol)-4, los cuales tienen efecto sobre el sistema de nociceptina/receptor ORL-1 y también sobre el sistema receptor oploide p, y que se presentan de manera más específica, por medio de una eficacia selectiva en el tratamiento del dolor crónico (entre otros, el dolor inflamatorio, el dolor visceral, el dolor de tumores, de preferencia, el dolor neuropático), sin mostrar al mismo tiempo una eficacia pronunciada en el dolor nociceptivo agudo.
CO13014969A 2010-07-28 2013-01-28 Derivados de cis -tetrahidro -espiro(ciclohexan-1.1-pirido[-3.4-b]indol)4-amina CO6650378A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10007822 2010-07-28

Publications (1)

Publication Number Publication Date
CO6650378A2 true CO6650378A2 (es) 2013-04-15

Family

ID=44315152

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13014969A CO6650378A2 (es) 2010-07-28 2013-01-28 Derivados de cis -tetrahidro -espiro(ciclohexan-1.1-pirido[-3.4-b]indol)4-amina

Country Status (32)

Country Link
US (3) US20120029006A1 (es)
EP (2) EP2598503B1 (es)
JP (1) JP5898193B2 (es)
KR (1) KR101927054B1 (es)
CN (1) CN103025732B (es)
AR (1) AR082393A1 (es)
AU (1) AU2011285217B8 (es)
BR (1) BR112013003642A2 (es)
CA (1) CA2806633C (es)
CL (1) CL2013000266A1 (es)
CO (1) CO6650378A2 (es)
CY (2) CY1115186T1 (es)
DK (2) DK2740476T3 (es)
EC (1) ECSP13012409A (es)
ES (2) ES2474644T3 (es)
HK (1) HK1183660A1 (es)
HR (2) HRP20140569T1 (es)
HU (1) HUE042732T2 (es)
IL (1) IL223756A (es)
LT (1) LT2740476T (es)
MX (1) MX2013000751A (es)
NZ (1) NZ607529A (es)
PE (1) PE20130808A1 (es)
PL (2) PL2740476T3 (es)
PT (2) PT2740476T (es)
RS (2) RS53341B (es)
RU (1) RU2592283C2 (es)
SI (2) SI2740476T1 (es)
TR (1) TR201821273T4 (es)
TW (1) TWI582092B (es)
WO (1) WO2012013343A1 (es)
ZA (1) ZA201301505B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2970284T (pt) 2013-03-15 2018-02-08 Gruenenthal Gmbh Cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclo-hexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
EA034898B1 (ru) 2016-01-13 2020-04-03 Грюненталь Гмбх Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана
TWI640514B (zh) 2016-01-13 2018-11-11 歌林達有限公司 ３－（羧甲基）－８－胺基－２－側氧基－１，３－二氮－螺－［４．５］－癸烷衍生物
AU2017206908B2 (en) 2016-01-13 2020-07-09 Grünenthal GmbH 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018008644A (es) 2016-01-13 2018-11-19 Gruenenthal Gmbh Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
BR112018014302B1 (pt) 2016-01-13 2023-10-17 Grünenthal GmbH Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
PL3407888T3 (pl) 2016-01-26 2021-08-30 Intra-Cellular Therapies, Inc. Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
TW201832765A (zh) * 2017-02-24 2018-09-16 德商歌林達有限公司 膀胱內投藥用於治療膀胱痛之組合物
TW201908295A (zh) 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物
JP2019073493A (ja) * 2017-10-17 2019-05-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヴルヴォディニアの治療
WO2020030777A1 (en) 2018-08-10 2020-02-13 Grünenthal GmbH Composition for treating urinary frequency and/or urinary urgency
MX2021011986A (es) * 2019-04-04 2021-11-03 Intra Cellular Therapies Inc Metodos de tratamiento de dolor neuropatico.
MX2022007994A (es) 2019-12-26 2022-09-23 Gilgamesh Pharmaceuticals Inc Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos.
RU2725197C1 (ru) * 2020-02-12 2020-06-30 федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации Метод оценки висцеральной гиперчувствительности
CA3172046A1 (en) 2020-02-18 2021-08-26 Gilgamesh Pharmaceuticals, Inc. Specific tryptamines for use in the treatment of mood disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10323172A1 (de) 2003-05-22 2004-12-09 Ina-Schaeffler Kg Treiberstufe für ein Solenoidventil
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102004019502A1 (de) 2004-04-22 2005-11-17 Rheinmetall Landsysteme Gmbh Munitionsmagazin
DE102004039382A1 (de) 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US8425881B2 (en) 2005-03-18 2013-04-23 Colgate-Palmolive Company Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
EP1869344A2 (en) 2005-04-12 2007-12-26 The Ohio State University All wheel drive electrically-variable transmission
WO2007112490A1 (en) 2006-03-30 2007-10-11 Innovative Dairy Products Pty Ltd As Trustee For The Participants Of The Cooperative Research Centre For Innovative Dairy Products Chromosomal blocks as markers for traits
WO2007117173A1 (en) 2006-04-07 2007-10-18 Closed Joint Stock Company 'biocad' Fluid dispensing system, methods and products
DE102006019597A1 (de) * 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2008100941A2 (en) 2007-02-12 2008-08-21 Correlogic Systems Inc. A method for calibrating an analytical instrument
CL2009000731A1 (es) * 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
PT2970284T (pt) * 2013-03-15 2018-02-08 Gruenenthal Gmbh Cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclo-hexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina

Also Published As

Publication number Publication date
CY1115186T1 (el) 2017-01-04
CN103025732B (zh) 2016-06-01
LT2740476T (lt) 2018-12-27
CY1120993T1 (el) 2019-12-11
CN103025732A (zh) 2013-04-03
RU2592283C2 (ru) 2016-07-20
PL2598503T3 (pl) 2014-08-29
AU2011285217B8 (en) 2014-04-24
US20120029006A1 (en) 2012-02-02
HK1183660A1 (en) 2014-01-03
BR112013003642A2 (pt) 2016-09-06
DK2598503T3 (da) 2014-04-14
PT2598503E (pt) 2014-05-06
HUE042732T2 (hu) 2019-07-29
KR101927054B1 (ko) 2018-12-10
EP2740476A1 (de) 2014-06-11
JP5898193B2 (ja) 2016-04-06
RS58036B1 (sr) 2019-02-28
HRP20182078T1 (hr) 2019-02-08
US20160159787A1 (en) 2016-06-09
AU2011285217A8 (en) 2014-04-24
EP2598503B1 (de) 2014-03-26
RS53341B (en) 2014-10-31
WO2012013343A1 (de) 2012-02-02
US20170313703A1 (en) 2017-11-02
CA2806633A1 (en) 2012-02-02
ZA201301505B (en) 2014-08-27
JP2013532669A (ja) 2013-08-19
CA2806633C (en) 2019-08-20
CL2013000266A1 (es) 2013-05-24
AR082393A1 (es) 2012-12-05
TR201821273T4 (tr) 2019-01-21
MX2013000751A (es) 2013-01-29
PE20130808A1 (es) 2013-07-06
PT2740476T (pt) 2019-03-18
TW201204724A (en) 2012-02-01
ECSP13012409A (es) 2013-06-28
DK2740476T3 (en) 2019-01-14
EP2598503A1 (de) 2013-06-05
ES2708930T3 (es) 2019-04-12
ES2474644T3 (es) 2014-07-09
AU2011285217B2 (en) 2014-04-10
EP2740476B1 (de) 2018-12-05
PL2740476T3 (pl) 2019-06-28
SI2598503T1 (sl) 2014-05-30
HRP20140569T1 (hr) 2014-08-15
AU2011285217A1 (en) 2013-03-14
RU2013108696A (ru) 2014-09-10
SI2740476T1 (sl) 2019-02-28
IL223756A (en) 2015-06-30
KR20130098315A (ko) 2013-09-04
NZ607529A (en) 2014-05-30
TWI582092B (zh) 2017-05-11

Similar Documents

Publication Publication Date Title
CO6650378A2 (es) Derivados de cis -tetrahidro -espiro(ciclohexan-1.1-pirido[-3.4-b]indol)4-amina
CL2018003821A1 (es) Compuestos de indol sustituidos con (1,2,4)triazolo(1,5-a)piridinilo.
BR112018015283A2 (pt) compostos orgânicos
DK3233852T3 (da) Tetrahydro-pyrido[3,4-b]indoler som østrogenreceptormodulatorer og anvendelser deraf
MX2021014508A (es) Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
ECSP11011189A (es) Moduladores de los receptores tipo toll
EP2480079A4 (en) PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR
CL2013000225A1 (es) Forma de dosificacion farmaceutica que contiene 6´-fluoro-(n-metil)-o-n,n,-dimetil)-4-fenil-4´,9´-dihidro-3´-h-espiro[ciclohexan-1,1´-pirano[3,4,b])indol]-4-amina para el tratamiento de dolor neuropatico.
BR112012003266A2 (pt) sistema de tração funicular agrícola com propulsão elétrica
CL2009000724A1 (es) Compuestos derivados de 1,2,3,4-tetrahidro-pirido[3,4-b]indol, moduladores del receptor de histamina, serotonina y dopamina; composicion farmaceutica; kit farmaceutico; y uso para tratar un trastorno cognitivo, psicotico, mediado por neurotransmisores y/o neurologico.
ES2643164T3 (es) Indol 7-sustituido como inhibidores de Mcl-1
ITUA20162334A1 (it) Gruppo di connessione per l’accoppiamento di un sistema ausiliario di trazione a una carrozzina per disabili
GT201200247A (es) Formulaciones orales y sales lipofílicas de metilnaltrexona
BR112013014854A8 (pt) compostos de n-(1h-indazol-4-il)imidazo [1,2-a] piridina-3-carboxamida substituídos como inibidores de tirosina quinase de receptor tipo iii
SI2820016T1 (sl) N-(5s,6s,9r)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5h- ciklohepta (b)piridin-9-il-4-(2-okso-2, 3-dihidro-1h-imidazo(4,5-b) piridin-1-il) piperidin-1-karboksilat, hemisulfatna sol
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
NI201000138A (es) Compuestos
HK1149935A1 (en) Spiro indole derivatives for the treatment of parasitic diseases
JO2887B1 (en) Spiro-pyridine compounds as ORL-1 receptor antagonists
AR093916A1 (es) Cepa de bifidobacterium animalis ssp. animalis
BR112012001953A2 (pt) derivado indol ou seu sal farmaceuticamente aceitável
BR112013012117A2 (pt) sistema de distribuição de fármacos iontoforético coempacotado autocontido ativado por usuário
ZA201700110B (en) Compounds comprising 1,1',2,5'-tetrahydrospiro[indole-3,2'-pyrrole]-2,5'-dione system as inhibitors p53-mdm2 protein-protein interaction
DK2491028T3 (da) Indazol og pyrazolopyridine forbindelser som CCR1 receptor antagonister
PL2433909T3 (pl) Urządzenie do dezynfekcji wody z użyciem ozonu

Legal Events

Date Code Title Description
FC Application refused